Explain me type 2 hypersensitivity
type 2 hypersensitivity antibody-mediated cytotoxic mechanisms
type II hypersensitivity clinical examples diseases autoimmune
| Antibody | Role |
|---|---|
| IgM | Most efficient at activating complement (classical pathway) |
| IgG1, IgG2, IgG3 | Complement fixation + ADCC |
| IgG4 | Generally does NOT fix complement; may block rather than activate |
| Disease | Target Antigen | Mechanism | Effect |
|---|---|---|---|
| ABO-incompatible transfusion reaction | RBC surface antigens (A/B) | Complement lysis | Intravascular hemolysis |
| Hemolytic disease of the newborn (HDN) | Rh (D) antigen on fetal RBCs | Complement + ADCC | Fetal/neonatal hemolysis |
| Autoimmune hemolytic anemia (AIHA) | RBC antigens | Complement + opsonization | Hemolysis, anemia |
| Goodpasture's syndrome | α3 chain of type IV collagen (GBM) | Complement + ADCC | Glomerulonephritis + pulmonary hemorrhage |
| Pemphigus vulgaris | Desmoglein 1 & 3 (epidermal cadherins) | Antibody disrupts cell adhesion | Bullous skin lesions, mucosal blistering |
| Myasthenia gravis | Nicotinic acetylcholine receptor (nAChR) | Receptor blockade + degradation | Progressive muscle weakness |
| Graves' disease | TSH receptor (TSHR) | Receptor stimulation (agonistic Ab) | Hyperthyroidism |
| Immune thrombocytopenic purpura (ITP) | Platelet GPIIb/IIIa | Opsonization → phagocytosis | Thrombocytopenia, bleeding |
| Feature | Type I | Type II | Type III | Type IV |
|---|---|---|---|---|
| Mediator | IgE | IgG / IgM | IgG complexes | T cells |
| Antigen location | Soluble (extracellular) | Cell surface / matrix | Soluble (circulating) | Intracellular / tissue |
| Onset | Minutes | Hours | Hours–days | Days |
| Complement involved | No | Yes (often) | Yes | No |
| Example | Anaphylaxis | Goodpasture's | SLE | Contact dermatitis |
Explain this
type 2 hypersensitivity subtypes opsonization complement dysfunction
| Disease | Target |
|---|---|
| Autoimmune Hemolytic Anemia (AIHA) | Antibodies against RBCs |
| Immune Thrombocytopenic Purpura (ITP) | Antibodies against platelets (GpIb/IX or GpIIb/IIIa) |
| Disease | Target |
|---|---|
| ANCA-mediated vasculitis | Neutrophil cytoplasmic antigens → vessel inflammation |
| Acute rheumatic fever (heart) | Cardiac tissue (molecular mimicry with Strep antigens) |
| Goodpasture's syndrome | Collagen type IV in glomerular and alveolar basement membrane |
| Disease | Antibody Target | Effect |
|---|---|---|
| Myasthenia gravis | Nicotinic ACh receptor (nAChR) | Blocks receptor → reduced muscle contraction → weakness |
| Graves' disease | TSH receptor (TSHR) | Stimulates receptor → overproduction of thyroid hormone → hyperthyroidism |
| Subtype | Mechanism | Cell Destroyed? | Examples |
|---|---|---|---|
| Opsonization & Phagocytosis | Ab + C3b coat cell → macrophage eats it | Yes | AIHA, ITP |
| Complement-mediated Inflammation | Ab activates complement → WBC recruitment → tissue damage | Yes (via inflammation) | Goodpasture's, Rheumatic fever, ANCA vasculitis, Pemphigus |
| Antibody-mediated Dysfunction | Ab blocks or stimulates receptor | No | Myasthenia gravis, Graves' disease |
"Type 2 hypersensitivity is because of antibody's action in 3 ways — mechanism for destruction of a cell..."